Dual diagnosis treatment for Boynton Beach — one team, both diagnoses, together.

For Boynton Beach residents, RECO Health's Delray Beach campus is a twelve-minute drive south on Federal Highway — close enough that PHP or IOP fits into an existing work and family schedule. In-house addiction psychiatry manages MAT (buprenorphine, naltrexone, acamprosate) and psychotropic medication (sertraline, lithium, quetiapine, aripiprazole) on a single unified plan, closing the fragmented-prescribing gap that drives relapse in traditional referral models. Trauma-informed therapists deliver CPT, Prolonged Exposure, and EMDR; on-site rTMS and ketamine services support treatment-resistant presentations.

Boynton Beach sits seven miles north of Delray Beach along Federal Highway, and for residents in Renaissance Commons, Ocean Ridge, or Quantum Park, the twelve-minute drive south to RECO Health is shorter than the run to a typical Boynton supermarket. That proximity matters clinically: it means a full continuum of care — detox, residential, PHP, IOP, and outpatient — can integrate into an existing daily life without pulling a client out of work, family, or the daily routines that stabilize recovery.

Why sequential treatment fails for co-occurring disorders

The addiction field spent decades separating substance use treatment from psychiatric treatment, and the outcome data is now unambiguous. Sequential treatment — the “get sober first, then we’ll address the mental health” model — produces materially worse outcomes than integrated treatment on every meaningful metric: relapse rate, psychiatric symptom burden, treatment completion, and one-year abstinence.

The mechanism is straightforward. The untreated diagnosis destabilizes the treated one. Untreated major depression during addiction treatment predicts early relapse; active substance use during depression treatment blocks antidepressant response and disrupts the sleep architecture required for mood regulation. PTSD symptoms that surface in early sobriety without a trauma-informed response drive clients back to the substance that suppressed them.

RECO Health’s dual diagnosis treatment program operates on the standard of care established by SAMHSA and reinforced across two decades of outcome research: integrated care delivered by the same clinical team, in the same building, on one unified treatment plan. Every clinician on the case — psychiatrist, primary therapist, group facilitator, case manager — carries dual training in substance use and psychiatric disorders.

The high-prevalence co-occurring diagnoses

Major depressive disorder, PTSD, generalized anxiety disorder, bipolar I and II, and adult ADHD are the psychiatric conditions most commonly co-occurring with substance use disorder. RECO screens all five with validated instruments at intake: PHQ-9 for depression, PCL-5 for PTSD, GAD-7 for anxiety, MDQ for bipolar spectrum, and ASRS for adult ADHD. Positive screens route to a full diagnostic evaluation by the in-house psychiatry team within the first seventy-two hours.

Each diagnosis carries a defined evidence-based pathway inside the program. Depression is treated with an SSRI (sertraline, escitalopram) or SNRI where indicated, paired with weekly CBT and behavioral activation. PTSD is treated with CPT, prolonged exposure, or EMDR once the client’s window of tolerance supports processing. Bipolar disorder receives mood stabilizer optimization — lithium, lamotrigine, or an atypical antipsychotic such as quetiapine or aripiprazole — before any antidepressant is layered in, to reduce the risk of induced hypomania. Adult ADHD is managed with a non-stimulant (atomoxetine, guanfacine) as first-line in early recovery; stimulants are used cautiously, under monitoring, when clinically justified.

For clients with treatment-resistant depression that has failed at least two adequate antidepressant trials, RECO offers rTMS on-site — typically 3,000 pulses per session at 120% of motor threshold, delivered five days a week for six weeks — and IV ketamine or intranasal esketamine under psychiatric supervision.

MAT and psychotropic medication managed by one psychiatrist

One of the most preventable relapse pathways in co-occurring care is fragmented prescribing. When a primary care physician manages the antidepressant, an outside psychiatrist manages the mood stabilizer, and an MAT provider prescribes buprenorphine, no single clinician sees the interaction map, and no one carries responsibility for the full regimen.

RECO closes that gap by design. The same in-house addiction psychiatrist prescribes and coordinates every medication: buprenorphine or naltrexone for opioid use disorder, oral or extended-release naltrexone or acamprosate for alcohol use disorder, and the client’s psychotropic regimen — sertraline, aripiprazole, lithium, quetiapine, buspirone, or otherwise. CIWA-Ar guides alcohol withdrawal management on the detox side; COWS guides opioid withdrawal and buprenorphine induction. When a client is on lithium, hydration and renal function are tracked on protocol; when a client is on an atypical antipsychotic, metabolic labs are drawn on schedule.

Trauma is often the through-line

For a substantial share of dual diagnosis clients, unprocessed trauma sits upstream of both the substance use and the mood disorder. Treating the substance use in isolation can produce short-term abstinence, but the trauma continues to drive dysregulation — hypervigilance, intrusive imagery, sleep disruption, emotional numbing — until the client returns to the substance that suppressed the symptoms. Long-term outcomes depend on addressing the trauma directly.

RECO’s protocol begins with screening (PCL-5, ACE questionnaire) and stabilization: nervous system regulation skills drawn from DBT, grounding practice, sleep normalization, and pharmacologic support where indicated (prazosin for trauma nightmares, an SSRI for baseline symptom burden). Once the client demonstrates a workable window of tolerance — reliably able to titrate distress in session without dissociating or reaching for substances between sessions — the team moves into evidence-based processing: Cognitive Processing Therapy, Prolonged Exposure, or EMDR, matched to the client’s presentation and stated preference.

What to expect on the first visit

The first appointment at RECO is a two-hour biopsychosocial assessment conducted by a licensed clinician, not a sales call. It covers substance use history (drug of choice, quantity, frequency, last use, prior withdrawal history), psychiatric history, trauma history, medical comorbidities, family history, and current recovery supports. Screening instruments are administered as indicated — PHQ-9, GAD-7, PCL-5, MDQ, ASRS, AUDIT, DAST. The ASAM Criteria six dimensions structure the level-of-care recommendation: acute intoxication and withdrawal risk, biomedical conditions, emotional and cognitive conditions, readiness to change, relapse potential, and recovery environment.

By the end of the visit, the client leaves with a written level-of-care recommendation, a working diagnostic impression, a scheduled start date, and a verified insurance benefits summary. If detox is indicated (CIWA-Ar above 8 for alcohol, active opioid withdrawal, benzodiazepine dependence), the medical team can typically admit the same day.

Insurance and admissions from Boynton Beach

RECO Health is in-network with most major commercial insurance plans, including Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. The admissions team runs a verification of benefits before the first appointment so the client and family see deductible, coinsurance, and expected out-of-pocket cost in writing — for each level of care — before any commitment is made.

For Boynton Beach residents in Renaissance Commons, Hunters Run, or near Quantum Park, the drive south on Federal Highway or I-95 to RECO’s Delray Beach campus averages twelve minutes outside of rush hour. That drive time is short enough that PHP-level care — six hours of programming, five days a week — is feasible without relocating, and IOP is compatible with continued employment.

Serving residents of: Renaissance Commons, Ocean Ridge, Quantum Park, Hunters Run, Briny Breezes.